A combinatorial heterogeneous-homogeneous reactor configuration in which an array or groups of homogeneous fuel assemblies are interlinked together in a heterogeneous lattice. The present invention removes the limitation of a homogeneous reactor by providing a reactor concept that utilizes the inherent advantages of homogeneous fuel elements but in a heterogeneous fuel lattice arrangement that limits the power density of any one homogeneous fuel element and yet forms a reactor arrangement that is capable of producing any product demand of interest. The present invention provides a method for producing medical isotopes by the use of a modular reactor core comprised of homogeneous fuel assemblies arranged in a regular rectangular or triangular pitch lattice. The aqueous fuel solution is contained within individual fuel assemblies that are right circular cylinders clad in corrosion-resistant alloys such as stainless steel, zircalloy, zircalloy alloys, or other metal alloys that are resistant to corrosive fissile environments but preserve neutron economy. The fuel assemblies are supported below by a core plate that is tied directly to the lower reactor support structure. The bottom of each assembly opens into a common plenum area which provides a hydrodynamic communication/coupling path between the individual assemblies in the lattice. The fuel assemblies are supported above by an upper plate that is welded to each assembly tube. The top of each assembly opens to a common upper plenum which provides a means of thermodynamic pressure equalization among the four assemblies in the reactor core lattice.
|
1. A liquid fuel combinatorial medical isotope production reactor arrangement, comprising:
a. a modular reactor core having groups of symmetric homogeneous fuel assemblies interlinked together by a common upper plenum in a heterogeneous lattice arranged in a regular lattice;
b. an individual and removable cooling arrangement, reflux condenser, and sweep gas circuit for each homogeneous fuel assembly group;
c. a closed fuel circulation region within the reactor core;
d. a closed loop reactor cooling arrangement; and
e. a semi-closed loop radiolytic gas management arrangement being in fluid communication with the upper plenum.
21. A liquid fuel combinatorial medical isotope production reactor arrangement, comprising:
a. a modular reactor core having groups of symmetric homogeneous fuel assemblies interlinked together by a common upper plenum in a heterogeneous lattice arranged in a regular lattice, wherein the common upper plenum links together at least two individual symmetric fuel assemblies;
b. an individual and removable cooling arrangement, reflux condenser, and sweep gas circuit for each homogeneous fuel assembly group;
c. a closed fuel circulation region within the reactor core;
d. a closed loop reactor cooling arrangement; and
e. a semi-closed loop radiolytic gas management arrangement being in fluid communication with the upper plenum.
18. A liquid fuel combinatorial medical isotope production reactor arrangement, comprising:
a. a modular reactor core having homogeneous fuel assemblies;
b. an upper plenum which interlinks the fuel assemblies in a heterogeneous lattice, the upper plenum having a disk shaped housing with a flat bottom surface, a flat top surface, an inlet opening for each of the fuel assemblies formed in the flat bottom surface and at least one outlet opening formed in the flat top surface;
c. a cooling arrangement, reflux condenser, and sweep gas circuit for each of the homogeneous fuel assemblies;
d. a closed fuel circulation region within the reactor core;
e. a closed loop reactor cooling arrangement; and
f. a semi-closed loop radiolytic gas management arrangement being in fluid communication with the outlet opening of the upper plenum.
2. The reactor arrangement of
3. The reactor arrangement of
4. The reactor arrangement of
5. The reactor arrangement of
6. The reactor arrangement of
7. The reactor arrangement of
8. The reactor arrangement of
9. The reactor arrangement of
10. The reactor arrangement of
11. The reactor arrangement of
12. The reactor arrangement of
13. The reactor arrangement of
15. The reactor arrangement of
16. The reactor arrangement of
17. The reactor arrangement of
19. The reactor arrangement of
20. The reactor arrangement of
|
The invention is generally related to medical isotopes and, more particularly, to a medical isotope production reactor.
Technetium-99m (t1/2 6.02 hr) is the most widely used radioisotope in nuclear medicine, accounting for more than 80% of all diagnostic nuclear medicine procedures. Technetium-99m (99mTc) is almost exclusively produced from the decay of its 66-hour parent 99Mo. Projected world demand for 99Mo by the year 2008 was estimated at approximately 11,000 to 12,000 Ci per week (6 days pre-calibrated). The most common method of 99Mo production is based on neutron irradiation in a nuclear reactor of a U—Al alloy or electroplated target enriched to 93 wt % 235U. After irradiation, the 99Mo is extracted from the other fission products by radiochemical methods. Although the specific activity achieved by this method is several tens of kilocuries per gram of molybdenum, large amounts of radioactive wastes are generated as byproducts of the fission process and the problem of long-lived fission product management is the major disadvantage in the production of 99Mo by this method.
The use of aqueous homogeneous solution reactors or water boiler reactors presents an attractive alternative to the conventional target irradiation method of producing 99Mo in that solution reactors eliminate the need for targets and can operate at much lower power than required for a target reactor to produce the same amount of 99Mo. Specifically, the use of solution reactors for the production of medical isotopes is potentially advantageous because of their low cost, small critical mass, inherent passive safety, and simplified fuel handling, processing and purification characteristics. These advantages stem partly from the fluid nature of the fuel and partly from the homogeneous mixture of the fuel and moderator.
In general, homogeneous reactor systems are superior to heterogeneous reactor systems in their inherent safety characteristics which arise from their greater radiolytic gas production per energy release, thereby resulting in a considerably larger prompt negative temperature coefficient of reactivity. However, the modularity of heterogeneous reactor systems provides a greater degree of freedom and versatility in the fuel arrangement. If practical methods for handling a radioactive aqueous fuel system are implemented, the inherent simplicity of a heterogeneous-homogeneous combinatorial reactor should result in considerable economic gains in the production of medical isotopes.
The advantages of utilizing homogeneous reactor technology for medical isotope production applications has prompted several countries, including the U.S., Russia, and China, to initiate programs to assess the feasibility of applying this technology on a commercial basis.
U.S. Pat. No. 5,596,611 discloses a uranyl nitrate homogeneous reactor (100 kW to 300 kW) for the production of 99Mo. The reactor is immersed in a containment pool which serves as a heat removal media for the sensible and decay heat generated in the reactor. The reactor vessel is finned to enhance the heat transfer to the containment pool. The reactor operates in a continuous mode in which the radioactive waste products are recirculated back into the reactor. A portion of the uranyl nitrate solution from the reactor is directly siphoned off and passed through columns of alumina to fix some of the fission products, including 99Mo, on the alumina. The 99Mo and some fission products on the alumina column are then removed through elution with a hydroxide and the 99Mo is either precipitated out of the resultant elutent with alpha-benzoinoxime or passed through other columns.
U.S. Pat. No. 5,910,971 discloses a small (20 kW to 100 kW) dedicated uranyl sulfate homogeneous reactor for the production of 99Mo which operates in a batch mode for a period of several hours to a week. After shutdown and following a cool-down period, the resultant solution is pumped through a solid sorbent material that selectively adsorbs the 99Mo. The uranyl sulfate and all fission products not adhering to the sorbent are returned to the reactor vessel. The reactor uses internal cooling coils for heat removal.
Although homogeneous reactor system concepts offer many advantages and greater flexibility for the production of 99Mo, potential power instabilities, which result from radiolytic bubble formation and thermal agitation, generate reactivity variations that can impair continuous stable operation. As a result, static solution reactor systems are power limited and, therefore, the specific activity of the 99Mo achievable, is limited by solution cooling constraints and potential thermal instabilities.
The present invention is drawn to a combinatorial heterogeneous-homogeneous reactor configuration in which an array or groups of homogeneous fuel assemblies are interlinked together in a heterogeneous lattice. The present invention removes the limitation of a homogeneous reactor by providing a reactor concept that utilizes the inherent advantages of homogeneous fuel elements but in a heterogeneous fuel lattice arrangement that limits the power density of any one homogeneous fuel element and yet forms a reactor arrangement that is capable of producing any product demand of interest. The present invention provides a method for producing medical isotopes by the use of a modular reactor core comprised of homogeneous fuel assemblies arranged in a regular rectangular or triangular pitch lattice. The aqueous fuel solution is contained within individual fuel assemblies that are right circular cylinders clad in corrosion-resistant alloys such as stainless steel, zircalloy, zircalloy alloys, or other metal alloys that are resistant to corrosive fissile environments but preserve neutron economy. The fuel assemblies are supported below by a core plate that is tied directly to the lower reactor support structure. The bottom of each assembly can open into a common plenum area which provides a hydrodynamic communication/coupling path between the individual assemblies in the lattice. Alternately, the fuel assemblies can be isolated hydrodynamically from one another. The fuel assemblies are supported above by an upper plate that is welded to each assembly tube. The top of each assembly opens to a common upper plenum which provides a means of thermodynamic pressure equalization among the four assemblies in the reactor core lattice.
The present provides a liquid fuel reactor concept where no fuel is circulated outside the core region.
The present invention provides a homogenous fuel element that combines the inherent safety characteristics with a heterogeneous lattice array which limits the power density of any one homogeneous fuel assembly.
The present invention provides a homogeneous fuel element with individual heat removal, reflux condenser, and sweep gas circuits which are modular and removable from the core lattice for maintenance purposes.
The various features of novelty which characterize the invention are pointed out with particularity in the claims annexed to and forming part of this disclosure. For a better understanding of the present invention, and the operating advantages attained by its use, reference is made to the accompanying drawings and descriptive matter, forming a part of this disclosure, in which a preferred embodiment of the invention is illustrated.
In the accompanying drawing, forming a part of this specification, and in which reference numerals shown in the drawing designate like or corresponding parts throughout the same:
As seen in
The reactor core 12 is comprised of a modular heterogeneous lattice such as graphite, beryllium, water, steel or some other neutron reflecting material that minimizes neutron leakage and optimizes neutron economy which has a plurality of removable homogeneous fuel assemblies 18. The fuel assemblies 18 within the lattice are interlinked at a common upper plenum 19 to insure system thermodynamic stability.
The fuel assemblies 18 are typically grouped into symmetric subunits, as best seen in
The spacing between fuel assemblies 18 or assembly subgroups and, thus, the amount of interspersed neutron reflecting lattice material such as graphite, beryllium, water, steel, or some other neutron reflecting material that minimizes neutron leakage and optimizes neutron economy between fissile units can be adjusted by design to regulate the desired neutron interaction between homogenous fuel assemblies and, thus, the net design power level and isotope production capability of the reactor.
The reactor core 12 lattice geometric configurations can be of any regular array such as a rectangular array on a square pitch, a hexagonal array on a triangular pitch, or some other commonly used lattice geometric arrangement. The market demand for the product and, thus, the reactor power level will dictate the number of required fuel assemblies and the lattice configuration.
Regardless of the lattice structure, the individual fuel assemblies 18 within the reactor core 12 are grouped into symmetric subunits with each fuel assembly 18 being a self-contained cylindrical vessel 23 (
The fuel assembly cooling coil circuits 20 shown in
The common upper plenum is designed to provide: (1) a large solution-gas interface to reduce solution entrainment in the solution vapor/radiolytic gases escaping the solution surface; (2) a large volume to accommodate an emergency fluid expansion without affecting the solution-gas interface; and (3) a large volume for the sweep gas to mix, dilute, and cool the radiolytic gas emerging from the fuel solution surface. The individual homogeneous fuel assemblies 18 in each subunit share a common lower plenum 21 with the other fuel assemblies in the subgroup or with all of the fuel assemblies within the lattice as a means for promoting free convection circulation throughout the lattice subgroup or the lattice as a whole. The upper plenum of each homogeneous fuel assembly 18 opens into a common upper plenum 19 shared by all fuel assemblies 18 within the reactor core 12. This insures proper equilibration of the radiolytic and carrier gas emanating from each homogeneous fuel assembly and thereby providing for overall core thermodynamic stability.
The reactor core cooling system 14 is schematically illustrated in
The dome of surge tank 42 is swept with air using lines 50 to remove the hydrogen generated from the radiolytic decomposition of primary coolant. The volumetric flow of air is designed to maintain the hydrogen concentration in the air to approximately 2% by volume to prevent a fire hazard.
The packaged chilled water system 46 is designed to maintain the inlet reactor cooling water temperature to the reactor at 4 to 6 degrees Celsius. The flow rate through the reactor core 12 can be varied according to the inlet temperature to maintain the desired differential temperature, thereby accommodating different reactor loadings ranging from decay heat removal to full power operation.
The reactor gas management system 16 is best seen in
The sweep gas, which can be air, nitrogen, oxygen, or an equivalent, enters the upper portion of each fuel assembly via a perforated nozzle 52. This disperses the gas above the fuel surface (It is seen in
As seen in
The reactor gas management system 16, best seen in
The entrainment trap 58 is comprised of a silver activated metal (stainless steel) sponge which removes entrained liquid, iodine vapors, solid radioactive daughters of the fission gas, and activated particulates in the sweep gas. The metal sponge presents a large catalytic surface area for the capture of fission fragments and other particulates. The metal sponge is housed in a metal chamber located on each of the parallel gas lines leaving the reactor and prior to the inlet to the hydrogen recombiner equipment 60.
The hydrogen recombiner equipment 60 associated with each subunit of fuel assemblies 18 (best seen in
The gas mixture flow into the axial bed 68 can be driven by a blower not shown or can be used in a natural circulation mode. The natural circulation mode may be assisted by a heater (not shown) at the inlet 72. The heater also serves to remove any residual water not vaporized. The natural circulation mode is also assisted by the extended chimney 82 above the exit 74 of the axial bed 68. In the unlikely event that a hydrogen deflagration/detonation were to occur, the increased pressure would activate pressure relief mechanisms 84 at each end of metal housing 70 to isolate the axial bed 68 and vent the burning contents to a pressure relief container 86, thereby minimizing potential reactivity excursions.
The heat of the recombination reaction is removed in the gas cooler-condenser 62, illustrated in more detail in
A pressure regulating system 94, schematically illustrated in
The NOx removal system 102 functions to remove residual NOx from the gas mixture, thereby preventing potential corrosion of downstream equipment and acid contamination of the environment.
The radioactive gas disposal system 104 removes radioactive isotopes of xenon and krypton from the gas stream by holding up these noble gases for a time sufficient to permit decay of these isotopes to levels which are permissible for elevated release. The procedure implemented in the concept to remove NOx from the gas stream is to pass the gas mixture through a catalytic bed which contains zeolite or inorganic oxide substrate particles coated with ceria (cerium oxide), silica gel, or the equivalent. The catalytic action of the active coating removes a large percentage of any NOx formed from the radiolytic decomposition of the uranyl nitrate fuel base. The scrubbed gas mixture is then passed to the off-gas system which includes a set of HEPA filters and adsorption beds that contain sufficient quantities of adsorbing material to adsorb all of the xenon and all but krypton-85. The inert noble gas, nitrogen, and oxygen are monitored for radioactive content and released, if within specification, via the stack.
The 99Mo processing system, schematically illustrated in
During the 99Mo processing sequence, the fuel solution is passed through the separation columns 110 and collected in criticality safe storage columns 122 (
The fuel cleanup arrangement, schematically illustrated in
In the extraction section 124 the uranium and plutonium are extracted by multistage countercurrent contact with 30% V/O tributyl phosphate (TBP) in a paraffinic hydrocarbon diluent. Fission products, which have much lower distribution coefficients than uranium and plutonium, remain largely in the aqueous phase and leave the extraction section in the aqueous raffinate. Americium and curium, which are predominately trivalent, are similar to the rare-earth fission products in that they have relatively low distribution coefficients and thus remain in the raffinate 130 with the fission products. Neptunium is partly in the extractable hexavalent state and partly in the pentavalent state. However, in the fuel clean system concept, all the neptunium is converted to the hexavalent state to insure that the plutonium remains with the organic extract. Typically in the extraction section 124 centrifugal contactors are employed to disperse the phases and minimize the holdup, thereby reducing the potential for solvent degradation from intense fission product radioactivity.
In the scrubbing section 126 the small quantities of fission products carried by the organic solvent leaving the extraction section 124 are removed from the organic solvent by countercurrent washing with aqueous nitric acid. The fission product impurities join the aqueous raffinate 130 from the extraction section.
In the stripping section 128 the uranium and plutonium in the organic phase are back extracted to the aqueous by dilute (˜0.01M) nitric acid. The organic solvent form is then washed in the wash section 132 successively with 0.2M sodium carbonate and dilute nitric acid to remove trace radiolytic and hydrolytic decomposition products and then reused in the fuel cleanup arrangement.
The aqueous raffinate stream 130 containing the fission products is passed to an aqueous waste management/processing arrangement schematically illustrated in
The highly radioactive stream feed to the aqueous waste management/processing arrangement encompasses the bulk of the fission products which reside in the raffinate stream 130 of the fuel cleanup arrangement. This aqueous phase contains many curies per liter and must be cooled to prevent self-boiling. The long term activity of the fission products are segregated into intermediate Class C and low level Class A streams by selectively removing the Cs and Sr from the raffinate stream with ion exchange resins and disposing the resin as Class C waste. The fission products remaining in the raffinate stream are passed to a waste concentrator that concentrates the waste to a concentration level that is commensurate with a stabilization process and disposal as Class A waste. Because of potential self-heating of the fission products, the evaporator and bottom storage tanks are provided with cooling means.
As best seen in
All core reactivity changes are performed by adjusting the positions of the rod clusters in fine increments (notch-by-notch). The control rod cluster withdrawal movements are constrained to notch movements by mechanical electrical interlocks with the maximum rod speed being limited. The axial position of each rod cluster is controlled by a rack and pinion drive mechanism, or equivalent, which is actuated through a rear-reduction unit by a reversible, 3-phase, variable reluctance electric motor 136. The control rod drive mechanism and rod element assembly are separate parts that are coupled by a direct current magnet 137 located at the linkage between the cluster drive mechanism and each control rod element. The electromagnets of all control elements are wired so that when a valid scram signal is received, all the electromagnets are de-energized simultaneously, and the control rods fall freely by gravity into the core and then are decelerated for the last two inches by the air cushioning effect of the control rod piston riding in the cylinder formed by the walls of the rod housing.
While specific embodiments and/or details of the invention have been shown and described above to illustrate the application of the principles of the invention, it is understood that this invention may be embodied as more fully described in the claims, or as otherwise known by those skilled in the art (including any and all equivalents), without departing from such principles.
Inman, James B., Neeley, Gary W.
Patent | Priority | Assignee | Title |
10734126, | Apr 28 2011 | SHINE TECHNOLOGIES, LLC | Methods of separating medical isotopes from uranium solutions |
10946310, | Jan 13 2017 | Alternating flow column chromatography apparatus and method of use | |
10978214, | Jan 28 2010 | SHINE TECHNOLOGIES, LLC | Segmented reaction chamber for radioisotope production |
11361873, | Apr 05 2012 | SHINE TECHNOLOGIES, LLC | Aqueous assembly and control method |
11830637, | May 02 2008 | SHINE TECHNOLOGIES, LLC | Device and method for producing medical isotopes |
11862356, | Jan 28 2010 | SHINE TECHNOLOGIES, LLC | Segmented reaction chamber for radioisotope production |
11894157, | Jan 28 2010 | SHINE TECHNOLOGIES, LLC | Segmented reaction chamber for radioisotope production |
ER4324, | |||
ER8393, |
Patent | Priority | Assignee | Title |
2961391, | |||
2999060, | |||
3085966, | |||
3136700, | |||
5596611, | Dec 08 1992 | BWX TECHNOLOGIES, INC | Medical isotope production reactor |
5910971, | Feb 23 1998 | BWXT TECHNICAL SERVICES, GROUP, INC | Method and apparatus for the production and extraction of molybdenum-99 |
6280694, | Oct 20 1999 | Studsvik, Inc. | Single stage denitration |
DE1489682, | |||
GB763231, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Mar 03 2009 | Babcock & Wilcox Technical Services Group, Inc. | (assignment on the face of the patent) | / | |||
Mar 03 2009 | NEELEY, GARY W | BABCOCK & WILCOX TECHNICAL SERVICES GROUP, INC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 022338 | /0787 | |
Mar 03 2009 | INMAN, JAMES B | BABCOCK & WILCOX TECHNICAL SERVICES GROUP, INC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 022338 | /0787 | |
Jun 25 2015 | B&W TECHNICAL SERVICES GROUP, INC | BWXT TECHNICAL SERVICES GROUP, INC | CHANGE OF NAME SEE DOCUMENT FOR DETAILS | 038624 | /0259 |
Date | Maintenance Fee Events |
Dec 27 2017 | M1551: Payment of Maintenance Fee, 4th Year, Large Entity. |
Jan 03 2022 | M1552: Payment of Maintenance Fee, 8th Year, Large Entity. |
Date | Maintenance Schedule |
Jul 01 2017 | 4 years fee payment window open |
Jan 01 2018 | 6 months grace period start (w surcharge) |
Jul 01 2018 | patent expiry (for year 4) |
Jul 01 2020 | 2 years to revive unintentionally abandoned end. (for year 4) |
Jul 01 2021 | 8 years fee payment window open |
Jan 01 2022 | 6 months grace period start (w surcharge) |
Jul 01 2022 | patent expiry (for year 8) |
Jul 01 2024 | 2 years to revive unintentionally abandoned end. (for year 8) |
Jul 01 2025 | 12 years fee payment window open |
Jan 01 2026 | 6 months grace period start (w surcharge) |
Jul 01 2026 | patent expiry (for year 12) |
Jul 01 2028 | 2 years to revive unintentionally abandoned end. (for year 12) |